Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2023-02-08 Transaction in Own Shar…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
首次回购股份暨回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the company's share repurchase (buyback) plan and the progress of its implementation. It details the repurchase purpose, method, price, quantity, funding source, and progress as of a specific date. There are no financial statements or comprehensive financial reports included, only information about the share buyback activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buying back or selling its own shares.
2023-02-08 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement regarding the progress of a share repurchase program by 惠州市锦好医疗科技股份有限公司. It details the share buyback plan, including the purpose, method, price, quantity, funding source, and implementation period. It also provides an update on the progress of the repurchase as of a specific date. The document is short (1188 characters) and focuses on the status of the company's own share transactions rather than financial results or other report types. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2023-01-31 Chinese
持股5%以上股东减持股份进展公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the progress of shareholding reduction by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, shareholding before and after reduction, reduction methods, timing, and risk disclosures related to the share reduction plan. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, specifically about a significant shareholder reducing their stake. The document length is short and focused solely on shareholding changes, not a full report or announcement of a report publication.
2023-01-29 Chinese
关于2022年股权激励计划部分预留权益失效的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the invalidation of certain reserved equity rights under the 2022 equity incentive plan. It details board and shareholder meetings, approvals, and legal opinions related to the equity incentive plan, and finally announces that some reserved equity rights have expired due to not being granted within the stipulated time. The document is a formal announcement about a specific corporate action related to equity incentives, not a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is also not a voting result announcement or a proxy solicitation. The content fits best under Regulatory Filings (RNS) as it is a regulatory announcement about equity incentive plan status and related corporate governance matters.
2023-01-16 Chinese
2022年股权激励计划预留股票期权授予结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of a reserved stock option grant under a 2022 equity incentive plan by Huizhou Jin Hao Medical Technology Co., Ltd. It details the number of options granted, recipients, exercise price, exercise conditions, and the impact on the company's financials. It is a formal disclosure of a stock option grant event, including specifics on the grant and exercise terms, but it is not a full financial report or audit report. This type of document fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through stock option grants. The document length is 2508 characters, which is consistent with an announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2023-01-16 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement regarding the progress of a share repurchase program by the company 惠州市锦好医疗科技股份有限公司. It details the repurchase plan, including purpose, method, price, quantity, funding source, and implementation period. It also provides an update on the repurchase progress as of a specific date. The document is short (1186 characters) and focuses on the status of the company's buyback activity rather than presenting financial statements or detailed financial analysis. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2023-01-02 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.